Jessica L Teeling Selected Research

Immunotherapy

1/2022	Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut.
1/2018	Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.
1/2017	STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.
11/2015	Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies.
1/2014	New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica L Teeling Research Topics

Disease

10	Inflammation (Inflammations) 01/2024 - 06/2011
9	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2014
5	Neuroinflammatory Diseases 01/2022 - 01/2014
4	Neoplasms (Cancer) 01/2017 - 09/2003
3	Retinal Degeneration 01/2023 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 06/2012
3	Lymphoma (Lymphomas) 01/2017 - 09/2003
2	Cognitive Dysfunction 01/2024 - 01/2018
2	Geographic Atrophy 01/2023 - 01/2019
2	Infections 01/2021 - 01/2019
2	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 01/2014
1	Rheumatoid Arthritis 01/2024
1	Atrophy 01/2023
1	Synucleinopathies 01/2022
1	Dementia (Dementias) 01/2022
1	Multiple System Atrophy 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Disease Progression 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Amyloidosis 10/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Bites and Stings (Sting) 01/2017
1	Obesity 10/2015
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2012
1	Brain Ischemia (Cerebral Ischemia) 06/2012
1	Hemolytic Anemia 07/2005
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2004
1	Immune System Diseases (Immune Disorders) 07/2004

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 06/2011
4	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2018
3	Retinaldehyde (Retinal)IBA 01/2023 - 01/2014
3	LipopolysaccharidesIBA 01/2020 - 07/2011
3	AntibodiesIBA 11/2015 - 01/2014
3	Fc Receptors (Fc Receptor)IBA 01/2014 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
2	Amyloid beta-PeptidesIBA 10/2019 - 01/2014
2	EpitopesIBA 11/2015 - 07/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2014 - 10/2012
2	Immunoglobulin G (IgG)IBA 06/2011 - 07/2004
2	Complement System Proteins (Complement)IBA 07/2006 - 09/2004
2	Rituximab (Mabthera)FDA Link 09/2004 - 09/2003
1	Antirheumatic Agents (DMARD)IBA 01/2024
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	EnzymesIBA 01/2023
1	Adenosine DeaminaseIBA 01/2023
1	alpha-SynucleinIBA 01/2022
1	SynucleinsIBA 01/2022
1	PrionsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Retinal Pigments (Pigments, Visual)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2018
1	CathepsinsIBA 10/2017
1	Cathepsin BIBA 10/2017
1	Hemoglobins (Hemoglobin)IBA 06/2012
1	HaptoglobinsIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Fc gamma receptor IIAIBA 07/2005
1	Monoclonal AntibodiesIBA 09/2004
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2004
1	Octoxynol (Triton X 100)IBA 09/2003
1	CaspasesIBA 09/2003

Therapy/Procedure

5	Immunotherapy 01/2022 - 01/2014
3	Therapeutics 01/2022 - 07/2004
1	Lasers (Laser) 01/2023